SpringWorks Therapeutics, Inc.’s SWTX share price has surged by 11.08%, which has investors questioning if this is right time to sell.

Teacher Retirement System of Texas increased its stake in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX – Free Report) by 26.4% ...

A stock is considered to be oversold if the RSI reading falls below 30. In trading on Tuesday, shares of SpringWorks Therapeutics Inc (Symbol: SWTX) entered into oversold territory, hitting an RSI ...

In a report released today, Yaron Werber from TD Cowen maintained a Buy rating on Ionis Pharmaceuticals (IONS – Research Report), with a price ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Regeneron (REGN – Research Report) and TG ...

Unfortunately for shareholders, while the SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) share price is up 55% in the last five years, that's less than the market return. Zooming in, the stock is up ...

SpringWorks Therapeutics portfolio features Ogsiveo for desmoid tumors and Gomekli for NF1‑plexiform neurofibromas. In fact, Ogsiveo’s revenues alone reached $172 million in 2024, supported by ...

Financial giants have made a conspicuous bearish move on SpringWorks Therapeutics. Our analysis of options history for SpringWorks Therapeutics SWTX revealed 9 unusual trades. Delving into the ...

SpringWorks Therapeutics (SWTX) saw the biggest retail follower increase among biotech stocks last week on Stocktwits, even as its shares tumbled more than 14%, marking their worst weekly decline ...